LOS ANGELES and ATLANTA, Jan. 6, 2022 /PRNewswire/ -- VeriCheck, Inc. (VCI), a leading provider of payments services and financial technology solutions, today announced the acquisition of Applied ...

In Lahoti v VeriCheck Inc, considering a second appeal in a cybersquatting case, the US Court of Appeals for the Ninth Circuit has upheld a district court’s finding that the trademark VERICHECK was ...

Together with the existing Vericheck ddPCR Empty-Full Capsid Kits for serotypes AAV5 and AAV9, the addition of the new kits for serotypes AAV2 and AAV8 extends the range’s suitability to approximately ...

DALLAS–(BUSINESS WIRE)–Generational Equity , a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client Applied Payment Systems, LLC to ...

VeriCheck Acquires Applied Payments and other Digital Transactions News briefs from 1/6/22 Digital Transactions News staff January 6, 2022 Acquiring, Automated Clearing House, Competitive Strategies, ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the recent launch of the Vericheck ddPCR™ Replication ...

The former owner of a check-guarantee and debt-collection business was accused Tuesday of turning over financial records of thousands of people to a neo-Nazi gang that authorities say engages in ...

Adeno-associated viruses (AAV) are powerful instruments in gene therapy. AAV particles comprise a protein capsid that along with the desired genome, containing both is considered a full capsid.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced the recent launch of the Vericheck ddPCR™ Replication Competent Lentivirus Kit and the Vericheck ddPCR Replication Competent AAV Kit. The ...